DCC constrains tumour progression via its dependence receptor activity

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The role of deleted in colorectal carcinoma (DCC) as a tumor suppressor is debated.
• DCC gene expression is reduced in advanced colorectal cancers.
• DCC acts as a dependence receptor, inducing apoptosis unless bound by netrin-1.

Purpose of the Study:

• To investigate the role of DCC-induced apoptosis in tumor progression.
• To determine if DCC loss-of-function predisposes to aggressive cancer development.
• To create a mouse model silencing DCC's pro-apoptotic activity.

Main Methods:

• Genetic silencing of DCC's pro-apoptotic activity in mice.
• Observation of spontaneous intestinal neoplasia.
• Assessment of intestinal tumor number and aggressiveness in an APC mutant context.

Main Results:

• Loss of DCC-induced apoptosis leads to spontaneous intestinal neoplasia at low frequency.
• DCC loss-of-function increases intestinal tumor number and aggressiveness in APC mutant mice.
• Development of highly invasive adenocarcinomas observed.

Conclusions:

• DCC functions as a tumor suppressor by triggering tumor cell apoptosis.
• DCC-induced apoptosis plays a critical role in controlling tumor progression.
• Loss of DCC's apoptotic function contributes to colorectal cancer development and aggressiveness.